CGP 25454A

CAS No. : 104391-26-6

CGP 25454A,104391-26-6
Product Details
For research use only. Not Intended for Therapeutic Use!
Cat No:I000250
Molecular Formula:C15H21Cl2N3O2
Molecular Weight:346.252
Price:Get quote
We would like to match the lowest price on market if possible.

Your information is safe with us.

Cat No:I000250
Cas No:104391-26-6
Product-Name:CGP 25454A
IUPAC Name:4-chloro-5-cyano-N-[2-(diethylamino)ethyl]-2-methoxybenzamide;hydrochloride

CGP 25454A is a novel and selective presynaptic dopamine autoreceptor antagonist.
In vitro: CGP 25454A increase the field-stimulated [3H]- and [14C]-overflow from rat striatal slices preloaded with [3H]dopamine and [14C]choline, indicating that CGP 25454A is able to enhance the release of both dopamine (DA) and acetylcholine (ACh). However, CGP 25454A is 12.9 times more potent in increasing, by 1/6 of the apparent maximal increase, the release of [3H]DA than that of [14C]ACh.
In vivo: CGP 25454A increase [3H]spiperone binding to receptors of the D2 family in rat striatum by 90-110% (ED50: 13 mg/kg i.p.). As a similar increase in [3H]spiperone binding is found with a variety of agents which increase the synaptic concentration of endogenous DA, the effect of CGP 25454A most probably reflects an enhanced release of DA under in vivo conditions. At 30-100 mg/kg, CGP 25454A inhibit [3H]spiperone binding in the pituitary of the same animals as a result of a blockade of postsynaptic DA receptors.

[1]. Bischoff S et al. CGP 25454A, a novel and selective presynaptic dopamine autoreceptor antagonist. Naunyn Schmiedebergs Arch Pharmacol. 1994 Sep;350(3):230-8.

Recommended Products
  • CAS No. :17700-09-3
    Product Name:


    Cat No: M084319 View details
  • CAS No. :17427-08-6
    Product Name:


    Cat No: M084320 View details
  • CAS No. :19278-82-1
    Product Name:

    3(2H)-Benzofuranone, 5-hydroxy-

    Cat No: M084321 View details
  • CAS No. :15719-81-0
    Product Name:


    Cat No: M084322 View details